Back to top
more

HealthEquity (HQY)

(Delayed Data from NSDQ)

$91.84 USD

91.84
642,993

+0.89 (0.98%)

Updated Aug 7, 2025 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (97 out of 244)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Sapna Bagaria headshot

Teladoc (TDOC) Up 73% Year to Date: Will the Rally Continue?

by Sapna Bagaria

Teladoc's (TDOC) presence in the growing telehealth industry with many deal wins and international expansion is likely to drive long-term growth.

Zacks Equity Research

ERFSF vs. HQY: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

ERFSF vs. HQY: Which Stock Is the Better Value Option?

Zacks Equity Research

ERFSF vs. HQY: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

ERFSF vs. HQY: Which Stock Is the Better Value Option?

Zacks Equity Research

ERFSF or HQY: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ERFSF vs. HQY: Which Stock Is the Better Value Option?

Zacks Equity Research

HealthEquity (HQY) Down 5.3% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

ERFSF vs. HQY: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

ERFSF vs. HQY: Which Stock Is the Better Value Option?

Zacks Equity Research

HealthEquity (HQY) Earnings & Revenues Beat Estimates in Q2

by Zacks Equity Research

HealthEquity (HQY) gains from solid segmental contributions in second-quarter fiscal 2020.

Zacks Equity Research

HealthEquity Acquires WageWorks, To Make Notable Investments

by Zacks Equity Research

HealthEquity (HQY) expects to complete its $80-100 million investment program within 24-36 months from now.

Zacks Equity Research

What's in the Cards for HealthEquity (HQY) in Q2 Earnings?

by Zacks Equity Research

Higher revenues and possible margin expansion are likely to aid HealthEquity (HQY) in Q2 earnings.

Zacks Equity Research

HealthEquity (HQY) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

HealthEquity (HQY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

HealthEquity (HQY) Gains But Lags Market: What You Should Know

by Zacks Equity Research

HealthEquity (HQY) closed at $58.62 in the latest trading session, marking a +0.15% move from the prior day.

Zacks Equity Research

HealthEquity (HQY) Stock Moves -0.51%: What You Should Know

by Zacks Equity Research

In the latest trading session, HealthEquity (HQY) closed at $60.69, marking a -0.51% move from the previous day.

Zacks Equity Research

HealthEquity (HQY) Gains But Lags Market: What You Should Know

by Zacks Equity Research

HealthEquity (HQY) closed at $68.50 in the latest trading session, marking a +1.41% move from the prior day.

Zacks Equity Research

HealthEquity (HQY) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

HealthEquity (HQY) closed at $77.80 in the latest trading session, marking a -0.13% move from the prior day.

Zacks Equity Research

AMN or HQY: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

AMN vs. HQY: Which Stock Is the Better Value Option?

Zacks Equity Research

Has HealthEquity (HQY) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Is (HQY) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Is HealthEquity (HQY) a Solid Growth Stock? 3 Reasons to Think " Yes "

by Zacks Equity Research

HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Equity Research

HealthEquity (HQY) Gains As Market Dips: What You Should Know

by Zacks Equity Research

In the latest trading session, HealthEquity (HQY) closed at $81.91, marking a +0.92% move from the previous day.

Urmimala Biswas headshot

Near-Term Outlook for Medical Services Industry Looks Bright

by Urmimala Biswas

The third-party medical services industry is expanding rapidly.

Zacks Equity Research

AMN or HQY: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

AMN vs. HQY: Which Stock Is the Better Value Option?

Zacks Equity Research

HealthEquity (HQY) in Focus: Stock Moves 6.7% Higher

by Zacks Equity Research

HealthEquity (HQY) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

Zacks Equity Research

Has HealthEquity (HQY) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Is (HQY) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

HealthEquity (HQY) Down 2% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

AMN vs. HQY: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

AMN vs. HQY: Which Stock Is the Better Value Option?

Zacks Equity Research

NovoCure (NVCR) Jumps: Stock Rises 7.1%

by Zacks Equity Research

NovoCure (NVCR) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.